Contribute to Research and to the GM1 Gangliosidosis Biobank
Cure GM1 partners with COMBINEDBrain on a GM1 biobank (biorepository) that helps advance research and therapy development. In 2026, Cure GM1 and Combined Brain also launched the GM1 Matrix, where families can share medical data for research from home.
COMBINEDBrain, a nonprofit with a biorepository consortium, represents and partners with 65 rare-disease advocacy groups in order to speed the path to clinical treatments for people with rare genetic neurodevelopmental disorders, by pooling efforts, studies, and data. Cure GM1 chose COMBINEDBrain as a partner for their state of art biorepository, dedicated team, and ability to quickly and efficiently fill a research gap that will benefit the entire GM1 research community.
What the GM1 Biobank does
The GM1 Biobank collects and stores patient samples, including blood, tissue and urine, which industry and academic researchers can request. These samples aid in the discovery of new biomarkers for diagnosis and research, and help identify treatment targets to improve the success of clinical studies. Sample procurement and storage are funded.
How patients can participate
All GM1 patients are welcome to contribute to the GM1 biorepository. Families may participate from the comfort of their homes to provide blood and urine samples. Please use our contact form if you can participate.
In addition, COMBINEDBrain travels to many events throughout the country and families may meet up with their team by following announcements of their schedule and going to the site for collection of samples.
How researchers can use samples
All biotech companies and researchers are welcome to request access to samples. To do so or to inquire about partnerships please use our contact form.
Many thanks to COMBINEDBrain for their support and partnership.
Visit our Research page to learn about other research efforts supported by the Cure GM1 Foundation.
